Pharmacogenetics of Parkinson’s Disease – Through Mechanisms of Drug Actions

In the last years due to development of molecular methods a substantial progress in understanding of genetic associations with drug effects in many clinical disciplines has been observed. The efforts to define the role of genetic polymorphisms in optimizing pharmacotherapy of Parkinson’s disease (PD...

Descripción completa

Detalles Bibliográficos
Autores principales: Droździk, Marek, Białecka, Monika, Kurzawski, Mateusz
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Bentham Science Publishers 2013
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3924251/
https://www.ncbi.nlm.nih.gov/pubmed/24532988
http://dx.doi.org/10.2174/1389202914666131210212521

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3924251/
https://www.ncbi.nlm.nih.gov/pubmed/24532988
http://dx.doi.org/10.2174/1389202914666131210212521

Ejemplares similares